2931 euglena
- 508
- -9-1.74%
euglena News
Convertible Stock List (Part 1) [Parabolic Signal Convertible Stock List]
○List of trading stocks market code stock name closing price SAR Tokyo Stock Exchange Prime ＜1377＞ Sakata seed 3605 3505 ＜1379＞ Hokuto 1829 1783 ＜1773＞ YTL 97 77 ＜1814＞ Daisue Ken 1552 1500 ＜1820＞ Nishimatsuken 4543 42 42
Yomeishu Manufacturing updates high prices [new high/new low updated brands]
New high price update stocks of Tokyo Stock Exchange Prime are Comsys Holdings ＜1721＞, 43 Kinden ＜1944＞ New low stocks are TOA Road Industry ＜1882＞ and Euglena ＜2931＞, 17 stocks “Tokyo Stock Exchange Prime,” “Tokyo Stock Exchange Standard,” and “Tokyo Stock Exchange Growth” new high price new low price new low 04/23 43 17 24 27 10 704/22 34
4/9 [Today's Investment Strategy]
[FISCO Specially Selected Brand] [Material Brand] AFC-HD Ams Life Science ＜2927＞ 913 yen (4/8) health food contract manufacturing (OEM) manufacturer. Earnings forecasts for the first half have been revised upward. Operating profit is expected to be 1,023 million yen (up 50.8% from the same period last year). That's up about 32% from the previous forecast. The domestic healthcare business and pharmaceutical business remained steady. Also, Saikaya, which is responsible for the department store business, turned into a surplus. The full-year forecast has not been revised. Operating profit for the fiscal year ended '8/24
Pay attention to Create SD and Euglena, are Iida GHD and ROHM doing soft
On the US stock market yesterday 8th, the NY Dow depreciated by 11.24 dollars to 38,892.80, the Nasdaq Composite Index was 5.44 points higher at 16,253.96, and the Chicago Nikkei 225 futures were 39450 yen, 60 yen higher than the Osaka Japan-China ratio. The exchange rate is 1 dollar = 151.70-80 yen. In today's Tokyo market, eBase ＜3835＞, which revised the earnings forecast for the fiscal year ending March 31, '24 upward, and CREATE SD (3148), which revised the earnings forecast for the fiscal year ending 24/5 upward, raised the dividend payout ratio from 30% to 35%
Global Algae Biofuel Industry Research 2024: An $18.84 Billion Market by 2033 Featuring Prominent Players - Algenol Biofuels, AlgaEnergy, Viridos, Cellana, and Euglena
Volume change rate ranking (around 9 o'clock) ~ Asahi, Shimamura, etc. are ranked
* In the volume change rate ranking, it is possible to know the interest of market participants, such as shopping trends, by comparing the average turnover for the last 5 days with the turnover on the day of distribution. ■Top Volume Change Rate [4/2 9:32 as of 9:32] (Last 5 Day Average Volume Comparison) Stock Code Stock Name Volume 5 Day Average Volume Volume Change Rate Stock Price Change Rate ＜2647＞ NF US Bonds 7 30000 107185.08 395.99% -0.0092
Convertible Stock List (Part 3) [Parabolic Signal Convertible Stock List]
○ List of sales conversion stocks market code stock name closing price SAR Tokyo Stock Exchange Prime ＜2922＞ Natori 2114 2179 ＜2931＞ Euglena 605 641 ＜3002＞ Gunze 5420 5680 ＜3036＞ Alconix 1435 1496 ＜3087＞ Doutor Day Less
Japanese Shares Track Other Asia Stocks Lower Despite China's Rate Cut
Japan's benchmark index followed other Asia-Pacific markets lower on Tuesday even after the Chinese central bank cut its five-year loan prime rate by 25 basis points to 3.95%. The Nikkei 225 retreated
Euglena Slightly Narrows 2023 Attributable Loss as Net Sales Grow
Euglena (TYO:2931) posted a slightly narrower 2023 loss attributable to owners after net sales jumped 4.7%. The food and cosmetics company's attributable loss was 2.65 billion yen, or 22.76 yen per ba
Euglena FY Loss Y2.65B Vs Loss Y2.67B
Euglena Co. Ltd. (2931.TO) Japan Year Ended December 31 GROUP 2023 2022 Revenue Y46.48 bln Y44.39 bln Operating Profit (Y1.46 bln) (Y3.46 bl
Euglena Widens Attributable Loss in Nine Month
Euglena (TYO:2931) widened its loss attributable to owners of the parent to 1.26 billion yen in the nine months ended Sept. 30, from 875 million yen a year ago as expenses more than offset the increas
Euglena 9-Mos Loss Y1.26B Vs Loss Y873.00M
Euglena Co. Ltd. (2931.TO) Japan Nine Months Ended September 30 GROUP 2023 2022 Revenue Y34.08 bln Y32.34 bln Operating Profit (Y959.0
Japanese Shares Extend Gains for Sixth Straight Trading Session; Euglena Rises 3%
The Japanese stock market extended its winning streak for the sixth consecutive session on Monday. This positive momentum was attributed to several factors, including the favorable impact of weaker US
Euglena Opens Call for Chief Future Officers Under 18 Years Old
Euglena (TYO:2931) opened the call for new chief future officers under the age of 18 who will work with the company, the Japanese biotechnology company said Friday. The company aims to create a sustai
Euglena 1H Loss Y914.00M Vs Loss Y465.00M
Euglena Co. Ltd. (2931.TO) Japan 1st Half Ended June 30 GROUP 2023 2022 Revenue Y22.81 bln Y21.58 bln Operating Profit (Y760.00 mln)
Euglena Sees Attributable Loss Fall in FY22
12:53 AM EST, 02/17/2023 (MT Newswires) -- Euglena (TYO:2931) trimmed its operating loss and attributable loss in the full-year 2022, thanks in part to a growth in net sales. Loss attributable to own
Euglena FY Loss Y2.67B Vs Loss Y5.04B
Euglena Co. Ltd. (2931.TO) Japan Year Ended December 31 GROUP 2022 2021 Revenue Y44.39 bln Y34.42 bln Operating Profit (Y3.46 bln) (Y6
Euglena Shares Surge After Fundraising Plan for Biofuel Project
By Kosaku Narioka Euglena Co. shares rose sharply Friday morning after the Japanese biotech company provided an upbeat guidance update and announced a plan to raise about 7.76 billion yen ($60.4 mill
Euglena: To Raise Y4.785B by Selling Bonds With Stock Acquisition Right to Mazda Motor, Dai-ichi Life
Euglena: To Raise Y4.785B by Selling Bonds With Stock Acquisition Right to Mazda Motor, Dai-ichi Life
Euglena: To Raise Y2.98B by Selling New Shares to Marui Group, Rohto Pharmaceutical at Y935 Apiece
Euglena: To Raise Y2.98B by Selling New Shares to Marui Group, Rohto Pharmaceutical at Y935 Apiece
Analysis
Price Target
No Data
